References
- 1Collins CS, Eggert CH, Stanson AJ, Garovic VD. Long-term follow-up of renal function and blood pressure after selective renal arterial embolization. Perspect Vasc Surg Endovasc Ther. 2010; 22(4): 254–60. DOI: 10.1177/1531003510395605
- 2Mohsen T, El-Assmy A, El-Diasty T. Long-term functional and morphological effects of transcatheter arterial embolization of traumatic renal vascular injury. BJU Int. 2008; 101(4): 473–7. DOI: 10.1016/S1569-9056(09)60723-5
- 3Chatziioannou A, Brountzos E, Primetis E, et al. Effects of superselective embolization for renal vascular injuries on renal parenchyma and function. Eur J Vasc Endovasc Surg. 2004; 28(2): 201–6. DOI: 10.1016/j.ejvs.2004.05.003
- 4Matsushita K, Mahmoodi BK, Woodward M, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012; 307(18): 1941–51. DOI: 10.1001/jama.2012.3954
- 5Levin A, Stevens PE, Bilous RW, et al. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements. 2013; 3(1): 1–150.
- 6Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989; 86(6 Pt 1): 649–52. DOI: 10.1016/0002-9343(89)90437-3
- 7Brown JR, Robb JF, Block CA, et al. Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury? Circ Cardiovasc Interv. 2010; 3(4): 346–50. DOI: 10.1161/CIRCINTERVENTIONS.109.910638
- 8Raposeiras-Roubin S, Abu-Assi E, Ocaranza-Sanchez R, et al. Dosing of iodinated contrast volume: A new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome. Catheter Cardiovasc Interv. 2013; 82(6): 888–97. DOI: 10.1002/ccd.24847
- 9Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33): 3021–104. DOI: 10.1093/eurheartj/ehy339
- 10Scosyrev E, Messing EM, Sylvester R, Campbell S, Van Poppel H. Renal function after nephron-sparing surgery versus radical nephrectomy: Results from EORTC randomized trial 30904. Eur Urol. 2014; 65(2): 372–7. DOI: 10.1016/j.eururo.2013.06.044
- 11Hsu RK, Hsu CY. The role of acute kidney injury in chronic kidney disease. Semin Nephrol. 2016; 36(4): 283–92. DOI: 10.1016/j.semnephrol.2016.05.005
- 12Sharma A, Mucino MJ, Ronco C. Renal functional reserve and renal recovery after acute kidney injury. Nephron Clin Pract. 2014; 127(1–4): 94–100. DOI: 10.1159/000363721
- 13Sharafuddin MJ, Marjan AE. Current status of carbon dioxide angiography. J Vasc Surg. 2017; 66(2): 618–37. DOI: 10.1016/j.jvs.2017.03.446
- 14Hom D, Eiley D, Lumerman JH, Siegel DN, Goldfischer ER, Smith AD. Complete renal embolization as an alternative to nephrectomy. J Urol. 1999; 161(1): 24–7. DOI: 10.1016/S0022-5347(01)62049-4
- 15Alavi JB, McLean GK. Hypertension with renal carcinoma. An effect of arterial embolization. Cancer. 1983; 52(1): 169–72. DOI: 10.1002/1097-0142(19830701)52:1<;169::AID-CNCR2820520130>3.0.CO;2-T
- 16Probert CS, Osborn DE, Watkin EM. Malignant hypertension due to embolisation of a clear cell renal carcinoma. Br J Urol. 1992; 70(1): 95–6. DOI: 10.1111/j.1464-410X.1992.tb15674.x